Combination niraparib and abiraterone for HRR-altered metastatic castration-resistant prostate cancer
2024 · Future Oncology · 4 citations
https://doi.org/10.1080/14796694.2024.2442900
BC Cancer Agency(CA)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
688
Citations
7
h-index
6
i10-index
Kim Nguyen is an academic researcher from BC Cancer Agency. The author has contributed to research in topics: Prostate Cancer Treatment and Research & PARP inhibition in cancer therapy & DNA Repair Mechanisms. The author has an h-index of 7, co-authored 12 publications.
Click to start Chat